TW349021B - Pharmaceutical compositions containing interleukin-12 for preventing graft versus host disease - Google Patents

Pharmaceutical compositions containing interleukin-12 for preventing graft versus host disease

Info

Publication number
TW349021B
TW349021B TW084100334A TW84100334A TW349021B TW 349021 B TW349021 B TW 349021B TW 084100334 A TW084100334 A TW 084100334A TW 84100334 A TW84100334 A TW 84100334A TW 349021 B TW349021 B TW 349021B
Authority
TW
Taiwan
Prior art keywords
host disease
pharmaceutical compositions
compositions containing
versus host
graft versus
Prior art date
Application number
TW084100334A
Other languages
English (en)
Chinese (zh)
Inventor
Megan Sykes
Stanley F Wolf
Original Assignee
Genetics Inst
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, Gen Hospital Corp filed Critical Genetics Inst
Application granted granted Critical
Publication of TW349021B publication Critical patent/TW349021B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW084100334A 1994-01-21 1995-01-16 Pharmaceutical compositions containing interleukin-12 for preventing graft versus host disease TW349021B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/186,529 US5573764A (en) 1994-01-21 1994-01-21 Use of interleukin-12 to prevent graft versus host disease

Publications (1)

Publication Number Publication Date
TW349021B true TW349021B (en) 1999-01-01

Family

ID=22685309

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084100334A TW349021B (en) 1994-01-21 1995-01-16 Pharmaceutical compositions containing interleukin-12 for preventing graft versus host disease

Country Status (14)

Country Link
US (2) US5573764A (fr)
EP (1) EP0739212B1 (fr)
JP (1) JP3825043B2 (fr)
AT (1) ATE215380T1 (fr)
AU (1) AU698410B2 (fr)
CA (1) CA2181568C (fr)
DE (1) DE69526206T2 (fr)
DK (1) DK0739212T3 (fr)
ES (1) ES2179096T3 (fr)
IL (1) IL112373A (fr)
PT (1) PT739212E (fr)
TW (1) TW349021B (fr)
WO (1) WO1995019786A1 (fr)
ZA (1) ZA95463B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
JP2000510813A (ja) * 1995-02-06 2000-08-22 ジェネテイックス・インスティテュート・インコーポレイテッド Ｉｌ−１２用処方
WO1997016203A1 (fr) * 1995-11-01 1997-05-09 Genetics Institute, Inc. Procedes d'administration d'il-12
EP0956301A2 (fr) * 1996-10-18 1999-11-17 Valentis Inc. Expression du gene il-12, systemes d'apport et utilisations
JP2001503258A (ja) * 1996-10-18 2001-03-13 バレンティス・インコーポレーテッド 遺伝子発現および搬送系および用途
AU6150498A (en) * 1997-02-07 1998-08-26 Wistar Institute, The Methods and compositions for the inhibition of interleukin-12 production
WO1998051327A1 (fr) * 1997-05-16 1998-11-19 Toray Industries, Inc. Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats
EP1516630A3 (fr) * 1997-10-31 2006-05-03 Wyeth Utilisation d'anticorps anti-il12 pour empêcher le rejet des greffes
US6080399A (en) * 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
US7115712B1 (en) * 1999-12-02 2006-10-03 Maxygen, Inc. Cytokine polypeptides
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
WO2003020904A2 (fr) * 2001-08-31 2003-03-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Procedes de generation de cellules cd4+ th1 humaines
US7718196B2 (en) * 2001-07-02 2010-05-18 The United States Of America, As Represented By The Department Of Health And Human Services Rapamycin-resistant T cells and therapeutic uses thereof
US20040175827A1 (en) * 2001-07-02 2004-09-09 Fowler Daniel H. Methods of generating human cd4+ th2 cells and uses thereof
WO2003038062A2 (fr) * 2001-10-31 2003-05-08 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Generation et utilisation de cellules tc1 et tc2
DE10248141B4 (de) * 2002-10-11 2007-04-19 Universitätsklinikum Hamburg-Eppendorf Nukleinsäuren und deren Verwendung für die Gentherapie
US7939058B2 (en) 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
BRPI0818287A2 (pt) * 2007-10-08 2015-11-03 Intrexon Corp células dendríticas manipuladas e usos para o tratamento do câncer.
US20100272863A1 (en) * 2009-04-24 2010-10-28 Griebel Jonathan M Soft shaped tortillas
US9878012B2 (en) 2010-05-18 2018-01-30 Neumedicines, Inc. IL-12 formulations for enhancing hematopoiesis
WO2012174056A1 (fr) 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation d'une lésion cutanée par il-12
CA2843014C (fr) 2011-07-27 2020-01-21 Neumedicines, Inc. Utilisation d'il-12 pour generer de l'erythropoietine endogene
US11951157B2 (en) 2011-10-11 2024-04-09 Universitat Zurich Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
EP2766035B1 (fr) * 2011-10-11 2018-03-28 Universität Zürich Prorektorat MNW Combinaison médicamenteuse comprenant de l'il-12 et un agent de blocage de molécules inhibitrices des lymphocytes t pour une thérapie anti-tumorale
JP2015505326A (ja) 2012-01-18 2015-02-19 ニューメディシンズ，インコーポレーテッド 放射線防護及び放射線誘発性毒性緩和のためのｉｌ−１２
WO2013158959A1 (fr) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions et procédés pour le traitement de la maladie du greffon contre l'hôte
CN115916261A (zh) * 2020-04-17 2023-04-04 小利兰·斯坦福大学董事会 工程化il-12和il-23多肽及其用途
US12071633B2 (en) * 2020-10-13 2024-08-27 Kriya Therapeutics, Inc. Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer
CA3234552A1 (fr) 2021-10-20 2023-04-27 Synthekine, Inc. Cytokines fc heterodimeres et leurs utilisations
US20240041939A1 (en) * 2021-12-17 2024-02-08 William Marsh Rice University Encapsulated cells expressing il-12 and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA931489B (en) * 1992-03-04 1993-10-28 Schering Corp Use of interleuken-10 to suppress graft-vs-host disease
DE4315127A1 (de) * 1993-05-07 1994-11-10 Behringwerke Ag Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease

Also Published As

Publication number Publication date
ATE215380T1 (de) 2002-04-15
EP0739212A1 (fr) 1996-10-30
WO1995019786A1 (fr) 1995-07-27
US5756085A (en) 1998-05-26
CA2181568C (fr) 2007-09-18
ES2179096T3 (es) 2003-01-16
DE69526206T2 (de) 2002-11-21
DK0739212T3 (da) 2002-06-03
US5573764A (en) 1996-11-12
JPH09508371A (ja) 1997-08-26
AU698410B2 (en) 1998-10-29
IL112373A0 (en) 1995-03-30
DE69526206D1 (de) 2002-05-08
PT739212E (pt) 2002-08-30
JP3825043B2 (ja) 2006-09-20
IL112373A (en) 2006-08-01
EP0739212B1 (fr) 2002-04-03
CA2181568A1 (fr) 1995-07-27
AU1687595A (en) 1995-08-08
ZA95463B (en) 1995-09-27

Similar Documents

Publication Publication Date Title
TW349021B (en) Pharmaceutical compositions containing interleukin-12 for preventing graft versus host disease
AU1270599A (en) Radioactive embolizing compositions
IL126755A0 (en) A pharmaceutical composition for improving implantation rates after in-vitro fertilization
NZ323456A (en) Pharmaceutical composition of an estrogen agonist/antagonist and a prostaglandin or a prostaglandin agonist/antagonist; useful for combination therapy for osteoporosis
AU2711295A (en) Combination treatment for inhibiting bone loss
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
GR3030317T3 (en) Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes.
ZA977524B (en) Process for the preparation of bone cements comprising active compound.
MX9707535A (es) Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario.
EP0637450A3 (fr) Méthode et composition pour revigorer le tissu cicatriciel.
AP9801269A0 (en) Prostaglandin agonists.
IT1280943B1 (it) Guida di estrazione per parti estraibili di mobili.
EP0640097A4 (fr) Compositions et procedes de vaccination contre les coronavirus.
PT1089968E (pt) Analogos de hormona tiroideia e metodos para a sua preparacao
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
IL118590A (en) Pharmaceutical composition for minimizing bone loss
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
GB9907571D0 (en) Compounds
IL147123A0 (en) Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
IL105474A0 (en) Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis
BG102229A (en) Endothelium receptor antagonists
HUP9702479A3 (en) New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same
HU9801925D0 (en) Sodium-hydrogen-change-inhibitors for producing pharmaceutical compositions for treating diseases caused by protozoons